V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013471 | 160012250 | 1.82 | 85 | Palliative (P) | null | 2020-07-09 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101145327 |
| 160013472 | 160012251 | 1.87 | 84.7 | null | 2022-01-10 | 2022-01-18 | Bevacizumab | 02 | null | CARBOPLATIN | 101351770 |
| 160013477 | 160012252 | 1.79 | 64.1 | Palliative (P) | null | 2018-10-06 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 100846649 |
| 160013480 | 160012253 | 1.8 | 90 | Palliative (P) | 2017-03-27 | 2017-03-29 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100404107 |
| 160013482 | 160012254 | 1.67 | 84.7 | null | 2017-09-11 | 2017-09-17 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101091689 |
| 160013483 | 160012255 | 1.61 | 61 | Adjuvant (A) | 2016-05-18 | 2016-05-31 | Bevacizumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101422530 |
| 160013490 | 160012256 | 1.75 | 68.6 | Palliative (P) | 2020-02-23 | 2020-03-29 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100634336 |
| 160013494 | 160012257 | 1.67 | 70 | null | 2021-10-22 | 2021-11-08 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101120069 |
| 160013495 | 160012258 | 1.71 | 102.4 | Palliative (P) | null | 2019-10-14 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101848588 |
| 160013502 | 160012259 | 1.54 | 63.4 | Palliative (P) | 2020-06-27 | 2020-12-11 | PACLITAXEL | 02 | N | PACLITAXEL | 100822254 |
| 160013507 | 160012260 | 1.54 | 70.5 | Palliative (P) | 2019-09-29 | 2019-10-06 | Bevacizumab | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100359082 |
| 160013509 | 160012261 | 1.55 | 107 | Palliative (P) | 2018-07-07 | 2019-07-28 | Carboplatin + Liposomal Doxorubicin | 02 | N | LIPOSOMAL DOXORUBICIN | 101424005 |
| 160013510 | 160012262 | null | 55.4 | null | 2017-09-06 | 2017-09-22 | Bevacizumab | null | null | CARBOPLATIN + PACLITAXEL | 100676438 |
| 160013512 | 160012263 | 1.73 | 79 | Palliative (P) | null | 2020-03-21 | GemCarbo Days 1+8 | N | N | CARBOPLATIN + GEMCITABINE | 100500509 |
| 160013518 | 160012264 | 1.44 | 50.8 | Palliative (P) | 2019-02-14 | 2019-02-16 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 101109799 |
| 160013519 | 160012265 | 1.64 | 78.5 | 03 | 2016-02-14 | 2016-03-27 | Bevacizumab 15mg/kg | 02 | N | BEVACIZUMAB | 101756989 |
| 160013522 | 160012266 | 1.78 | 79.8 | Palliative (P) | 2018-12-14 | 2018-12-24 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN + GEMCITABINE | 101062105 |
| 160013529 | 160012267 | 1.74 | 90.85 | null | 2018-11-15 | 2018-11-15 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100748779 |
| 160013534 | 160012268 | 1.75 | 72.9 | null | 2017-07-20 | 2017-08-10 | Bevacizumab 7.5mg/kg | 02 | null | CISPLATIN + PEMETREXED | 101401548 |
| 160013535 | 160012269 | 1.69 | 62.15 | Neo-adjuvant (N) | 2017-11-05 | 2017-11-18 | Liposomal Doxorubicin (Caelyx) | N | N | LIPOSOMAL DOXORUBICIN | 100762176 |
| 160013537 | 160012270 | 1.71 | 88.1 | Palliative (P) | 2020-12-07 | 2020-12-13 | Bevacizumab 7.5mg/kg | 01 | N | CARBOPLATIN | 100680839 |
| 160013538 | 160012271 | 1.6 | 75 | Palliative (P) | 2018-10-26 | 2019-03-20 | GemCarbo Days 1+8 | N | null | CARBOPLATIN + GEMCITABINE | 101693406 |
| 160013540 | 160012272 | 1.79 | 75 | Palliative (P) | 2017-03-23 | 2017-04-06 | Bevacizumab 7.5mg/kg | 02 | N | LIPOSOMAL DOXORUBICIN | 100878532 |
| 160013549 | 160012273 | 1.78 | 70 | Palliative (P) | 2013-12-19 | 2013-12-22 | Bevacizumab 7.5mg/kg | 2 | N | CARBOPLATIN + GEMCITABINE | 100745459 |
| 160013551 | 160012274 | 1.89 | 64.25 | Palliative (P) | 2018-04-04 | 2018-04-08 | PACLITAXEL | 02 | N | PACLITAXEL | 101123134 |
| 160013553 | 160012275 | 1.83 | 81.55 | Neo-adjuvant (N) | 2017-10-05 | 2017-10-17 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101516505 |
| 160013559 | 160012276 | 1.84 | 99.7 | null | 2018-05-10 | 2018-05-25 | Bevacizumab | 02 | null | CARBOPLATIN + PACLITAXEL | 101811609 |
| 160013560 | 160012277 | 1.68 | 44 | null | 2019-09-02 | 2019-09-11 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101867369 |
| 160013561 | 160012278 | 1.77 | 54.5 | null | 2014-08-12 | 2014-09-02 | Bevacizumab 7.5mg/kg | 02 | null | DOCETAXEL + GEMCITABINE | 101466545 |
| 160013562 | 160012279 | 1.7 | 66.3 | null | 2017-08-25 | 2017-08-29 | Bevacizumab 7.5mg/kg | N | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101707020 |
| 160013566 | 160012280 | 1.73 | 84.7 | Adjuvant (A) | 2016-09-16 | 2018-07-14 | PACLITAXEL | 2 | N | PACLITAXEL | 101536081 |
| 160013567 | 160012281 | 1.63 | 64.8 | null | 2018-02-21 | 2018-02-23 | Bevacizumab | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101289929 |
| 160013570 | 160012282 | 1.89 | 104 | Palliative (P) | null | 2017-12-29 | Bevacizumab 15mg/kg | 2 | N | DOXORUBICIN + OLARATUMAB | 101399376 |
| 160013572 | 160012283 | 1.74 | 45.4 | Palliative (P) | 2020-11-03 | 2020-11-06 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101195534 |
| 160013573 | 160012284 | 1.65 | 60.6 | null | 2018-10-08 | 2018-10-09 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100664893 |
| 160013574 | 160012285 | 1.75 | 87.1 | Palliative (P) | 2018-08-31 | 2018-09-06 | Bevacizumab 7.5mg/kg | 01 | 2 | CARBOPLATIN | 100896757 |
| 160013577 | 160012286 | 1.85 | 56 | null | 2020-07-04 | 2020-07-07 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100577065 |
| 160013579 | 160012287 | 1.64 | 76.9 | null | 2017-05-03 | 2017-05-10 | Bevacizumab 7.5mg/kg | 02 | null | DOCETAXEL + GEMCITABINE | 101564724 |
| 160013581 | 160012288 | 1.88 | 98 | Neo-adjuvant (N) | 2018-06-26 | 2018-07-09 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101684169 |
| 160013584 | 160012289 | 1.8 | 83.4 | null | 2017-10-26 | 2017-10-28 | Bevacizumab 7.5mg/kg | 02 | null | DOXORUBICIN + OLARATUMAB | 101509078 |
| 160013591 | 160012290 | 1.7 | 51.45 | Palliative (P) | 2018-05-08 | 2018-07-03 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100491466 |
| 160013592 | 160012291 | 1.68 | 53.7 | null | 2020-03-27 | 2020-04-05 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101039644 |
| 160013594 | 160012292 | 1.87 | 88.2 | null | 2018-05-08 | 2018-05-08 | Carboplatin AUC 2 - 5 | null | null | CARBOPLATIN | 100606212 |
| 160013599 | 160012293 | 1.71 | 110.6 | Palliative (P) | null | 2017-07-27 | Liposomal Doxorubicin (Caelyx) | N | N | LIPOSOMAL DOXORUBICIN | 101287367 |
| 160013600 | 160012294 | 1.79 | 74.2 | Palliative (P) | 2017-05-03 | 2017-06-12 | Bevacizumab 15mg/kg | 02 | N | LIPOSOMAL DOXORUBICIN | 101626914 |
| 160013603 | 160012295 | 1.74 | 61 | Palliative (P) | null | 2017-10-15 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100351710 |
| 160013605 | 160012296 | 1.88 | 105 | null | 2017-11-14 | 2017-11-28 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101211297 |
| 160013606 | 160012297 | 1.93 | 84.5 | Palliative (P) | null | 2017-08-02 | Bevacizumab | 02 | N | DOCETAXEL + GEMCITABINE | 100956525 |
| 160013607 | 160012298 | 1.79 | 74 | Disease modification (D) | 2022-03-14 | 2022-05-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100190281 |
| 160013608 | 160012299 | 1.6 | 91.8 | null | 2017-06-27 | 2017-11-15 | Docetaxel+Gemcitabine (no prior RT) | null | null | DOCETAXEL + GEMCITABINE | 100087816 |